We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.75B
AUM Growth
+$188M
Cap. Flow
+$19.8M
Cap. Flow %
0.72%
Top 10 Hldgs %
19.69%
Holding
327
New
32
Increased
100
Reduced
149
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Industrials 19.87%
3 Technology 17.13%
4 Consumer Discretionary 9.66%
5 Communication Services 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APOG icon
51
Apogee Enterprises
APOG
$900M
$19.3M 0.7%
400,578
+370,458
+1,230% +$15.9M
AERI
52
DELISTED
Aerie Pharmaceuticals
AERI
$19.2M 0.7%
284,762
+9,563
+3% +$535K
OMCL icon
53
Omnicell
OMCL
$1.64B
$19M 0.69%
361,728
-17,846
-5% -$839K
MEI icon
54
Methode Electronics
MEI
$585M
$18.8M 0.68%
465,386
-22,954
-5% -$938K
AIN icon
55
Albany International
AIN
$1.74B
$18.7M 0.68%
310,886
-15,332
-5% -$948K
OIS icon
56
Oil States International
OIS
$501M
$18.3M 0.67%
571,053
-27,794
-5% -$935K
PRTY
57
DELISTED
Party City Holdco Inc.
PRTY
$18.3M 0.67%
1,199,821
-60,059
-5% -$922K
TILE icon
58
Interface
TILE
$2.04B
$18.2M 0.66%
794,690
-41,237
-5% -$977K
XPO icon
59
XPO
XPO
$23B
$17.8M 0.65%
514,963
+62,879
+14% +$2.28M
GBCI icon
60
Glacier Bancorp
GBCI
$6.32B
$17.8M 0.65%
458,973
-18,633
-4% -$727K
DY icon
61
Dycom Industries
DY
$12B
$17.7M 0.64%
187,387
-10,040
-5% -$1.03M
CBM
62
DELISTED
Cambrex Corporation
CBM
$17.5M 0.64%
334,707
+115,764
+53% +$5.77M
NUVA
63
DELISTED
NuVasive, Inc.
NUVA
$17.4M 0.63%
333,884
-16,405
-5% -$859K
FLOW
64
DELISTED
SPX FLOW, Inc.
FLOW
$17M 0.62%
389,468
-121,999
-24% -$5.58M
HCSG icon
65
Healthcare Services Group
HCSG
$1.51B
$16.8M 0.61%
389,227
-19,851
-5% -$788K
UMBF icon
66
UMB Financial
UMBF
$11B
$16.6M 0.6%
218,158
-10,266
-4% -$789K
POWI icon
67
Power Integrations
POWI
$3.29B
$16.2M 0.59%
444,002
-1,636
-0.4% -$59.3K
OXM icon
68
Oxford Industries
OXM
$560M
$15.9M 0.58%
191,873
+5,536
+3% +$446K
CRS icon
69
Carpenter Technology
CRS
$27.7B
$15.9M 0.58%
302,483
-85,675
-22% -$4.63M
CAMP
70
DELISTED
CalAmp Corp.
CAMP
$15.9M 0.58%
29,475
+489
+2% +$246K
RAMP icon
71
LiveRamp
RAMP
$2.3B
$15.3M 0.56%
511,218
-292,844
-36% -$8.02M
DNOW icon
72
DNOW Inc
DNOW
$2.81B
$15.3M 0.56%
+1,145,770
New +$15.1M
BANR icon
73
Banner Corp
BANR
$2.4B
$15.1M 0.55%
250,794
-10,596
-4% -$622K
GMED icon
74
Globus Medical
GMED
$11B
$14.6M 0.53%
289,259
-15,306
-5% -$798K
ACIW icon
75
ACI Worldwide
ACIW
$5.61B
$14.4M 0.53%
585,574
+26,549
+5% +$647K

Similar funds

Rice Hall James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Rice Hall James & Associates held 327 positions worth $2.75B, up 7.3% from $2.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q2 2018 filing shows 32 new, 100 increased, 149 reduced and 29 closed positions. Its largest new stake was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M. The largest sale was Supernus Pharmaceuticals, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q2 2018 buy was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M.
  • Rice Hall James & Associates added most to Apogee Enterprises in Q2 2018, an estimated $15.9M increase.
  • Rice Hall James & Associates's biggest Q2 2018 reduction was Supernus Pharmaceuticals, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Viasat in Q2 2018, selling an estimated $17M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $2.75B portfolio in Q2 2018.
  • Rice Hall James & Associates opened 32 new positions and closed 29 in Q2 2018.
  • Rice Hall James & Associates's portfolio value rose 7.3% quarter-over-quarter to $2.75B.

Based on Rice Hall James & Associates's 13F filing for Q2 2018, filed 2 Aug 2018.